转化生长因子-β功能阻断可以预防心肌纤维化和压力过重的老鼠的腹功能障碍
Fumitaka Kuwahara1, Hisashi Kai, Keisuke Tokuda
1Cardiovascular Research Institute and Internal Medicine III, Kurume University School of Medicine, Kurume, Japan.
Circulation
|July 3, 2002
概括
转化生长因子-β (TGF-β) 通过激活纤维细胞,在压力过重的心脏中驱动心脏纤维化和腹功能障碍. 抑制TGF-β为这些疾病提供了潜在的治疗策略.
科学领域:
- 心血管研究研究心血管研究
- 进行心脏重塑.
- 纤维化机制 纤维化机制
背景情况:
- 高血压引起的心肌纤维化会损害心脏功能.
- 转化生长因子-β (TGF-β) 与心脏重塑和功能障碍有关.
研究的目的:
- 研究TGF-β在心肌重塑和心脏功能障碍中的作用,在压力过载的老鼠模型中.
- 为了探索TGF-β与纤维细胞激活,心肌纤维化和腹功能障碍的因果关系.
主要方法:
- 在Wistar大鼠中,通过上大动脉收缩诱导的压力过载.
- 评估纤维细胞激活,肌细胞缩和心肌纤维化.
- 评估心脏功能使用心声回声和血液动力学测量.
- 分析TGF-β mRNA表达和使用抗TGF-β 中和抗体进行干预.
主要成果:
- 纤维细胞激活在收缩后的3至7天达到峰值,随后在28日出现肌细胞缩和纤维化.
- 压力过载导致了正常的缩功能,但增加了左心室末端透缩压 (透缩功能障碍).
- 收缩后TGF-β mRNA表达增加,与纤维化发展相关.
- 抗TGF-β抗体抑制纤维细胞激活和纤维化,逆转腹功能障碍而不影响血压或心功能.
结论:
- TGF-β在调解心肌纤维化和透缩功能障碍方面发挥着关键作用,通过压力过重的心脏中的纤维细胞激活.
- 准TGF-β是一种有前途的治疗途径,可以预防心脏纤维化和腹功能障碍.
相关概念视频
01:22Heart Failure Drugs: β-Blockers
2.7K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
01:29Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K